SCM
TRIL

Segantii Capital Management’s Trillium Therapeutics Inc. TRIL Stock Holding History

Segantii Capital Management’s Portfolio TRIL Stock Details TRIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,135,000
Closed -$19.9M – 694
2021
Q3 		$19.9M Buy
+1,135,000
New +$19.9M 0.64% 23